Once a drug target is identified, it often takes decades until a chemical compound is developed that can hit the bullseye and ...

PolyActiva and RareSight collaborate to create innovative therapies for rare pediatric retinal diseases, aiming to transform ...

One such question, asked every now and then, is why humans float more easily in saltwater. There are a few places in the world where this is especially apparent, for example in the Dead Sea, or in the ...

Ultraviolet light causes damage to DNA, leads to cancer and photoaging: age spots and wrinkles. I was curious about this ...

A new technical paper titled “The van der Waals Gap: a Hidden Showstopper in Semiconductor Device Scaling” was published by ...

Learn how moving beyond ELISA can streamline your cell line development and boost productivity without compromising results.

The best hair repair treatments for stronger, shinier hair, according to over 200 women. Why and when to turn to bond ...

This dual cross-linking design lets the muscle switch stiffness on demand. In lab tests, its stiffness jumps from about 213 ...

The open-source model designs therapeutics across "any" modality with experimental validation for diverse real-world challenging targets.

PolyActiva, a clinical-stage biopharmaceutical company pioneering a novel drug delivery technology to improve outcomes for patients with ocular conditions, and RareSight, Inc., an ...